🇺🇸 FDA
Patent

US 8349886

Nitrogenated 5-membered heterocyclic compound

granted A61PA61P1/00A61P1/16

Quick answer

US patent 8349886 (Nitrogenated 5-membered heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P1/16, A61P1/18, A61P11/00